Abstract
A study comparing haloperidol and atypical antipsychotics for the management of agitation in patients hospitalized for acute myocardial infarction has found a small increased risk of death with haloperidol in the seven days after drug initiation. This risk was strongest in the first four days of treatment and was no longer present by day five, the researchers reported.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
